Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published December 21, 2023

Pfizer recalls sodium bicarbonate injection with glass particles risk

Pfizer recalls 4.2% sodium bicarbonate injection (5 mEq/10mL) with glass particles that could cause injury during IV use. This product was sold in specific lots and packaging.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0233-2024DrugPfizer ›
Take action

Contact the company

Recalling firmPfizer Inc.235 East 42nd Street · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer has recalled a specific type of sodium bicarbonate injection that contains glass particles. Using this product could cause injury if particles enter the bloodstream during intravenous administration. Read more at govinfonow.com/recall/32915-pfizer-recalls-sodium-bicarbonate-injection-with-glass-particles-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32915-pfizer-recalls-sodium-bicarbonate-injection-with-glass-particles-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0233-2024

Cite this page

“Pfizer recalls sodium bicarbonate injection with glass particles risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32915-pfizer-recalls-sodium-bicarbonate-injection-with-glass-particles-risk. Based on FDA recall #D-0233-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0233-2024%22&limit=1).

The FDA announced on Dec. 21, 2023, that Pfizer Inc. is recalling 4.2% Sodium Bicarbonate Injection due to the presence of glass particulate matter. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • Brand: Pfizer
  • Product: 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use
  • NDC: 0409-5534-24 (carton), 0409-5534-14 (case)
  • Lot: GX1542
  • Expiration: 01/01/2025
  • Manufacturer: Hospira, Inc., Lake Forst, IL 60045

The hazard

The recall addresses the presence of particulate matter identified as glass within the injection syringes. The FDA classified this hazard as Class I, indicating a situation where use could cause serious adverse health consequences or death.

Context

GovInfoNow's records show Pfizer Inc. has issued 71 other recalls since Nov. 26, 2012. Recent Pfizer recalls include an Aug. 4, 2025, epinephrine vial recall for sterility risks and a July 10, 2025, Bicillin L-A injectable recall for particulate risk. Other recent recalls of similar products include a Baxter sodium chloride injection recall on Aug. 17, 2026, for fiberglass particulates, a Sun Pharmaceutical DOXOrubin Liposome Injection recall on May 12, 2026, for glass particulates, and a B. Braun Medical sodium chloride injection recall on Aug. 19, 2026, for particulate matter.

How to tell if you have this one

Check for the product name '4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL)' with a glass syringe. Look for the lot number GX1542 and expiration date 01/01/2025 on the packaging.

  • Brand
    Pfizer
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA and Puerto Rico.
Recall numberProduct, codes & lotsQuantityNDC
D-0233-20244.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).; Lot GX1542, Exp. 01/01/202534000 Cartons—
D-0234-20248.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).; Lot HA7295, EXP 03/01/202521200 Cartons0409-4916-24, 0409-4916-14, 0409-6637-24, 0409-6637-14
D-0235-2024Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).; Lot GY2496, Exp 02/01/202524400 Cartons0409-1630-15, 0409-1630-10, 0409-9630-15, 0409-9630-05, 0409-4910-11, 0409-4910-34, 0409-4911-11, 0409-4911-34
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, lot number (GX1542), and expiration date (01/01/2025) on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide in the USA and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: Dec 21, 202312. FDA classified it Class I: Jan 17, 202423. Published in FDA’s Enforcement Report: Jan 24, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0233-2024 (December 21, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0233-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA